ANALYTICS & WHITEPAPERS
MOST POPULAR NEWS
HP's Happy Talk: Enough Already
The next two to five years will be difficult for HP, as it tries to transform itself into a consulting and high-end services business like IBM.
The New, New HP: Infrastructure In, Consumers Out
Will HP, the Leo Apotheker version, really be able to out-IBM Big Blue?
HP's Latest Fiasco: The Vanishing $99 TouchPad
HP killed the TouchPad and other WebOS devices, but they were available for $99 at various retailers. Unfortunately some buyers rushed to snap them up, but were shut out.
Johns Hopkins Execs: How To Make Medicine Smarter
CIO and chief medical information officer share lessons learned on electronic health records, embedded intelligence, risk reduction, and personalized medicine.
McAfee Blew Shady RAT Analysis, Kaspersky Says
Security expert Eugene Kaspersky dismissed the seriousness of the Shady RAT botnet and suggested McAfee was purposefully alarmist in its report.
RESOURCES AND EVENTS
Please Take Our Virtualization Management Survey
InformationWeek Analytics is conducting a survey on the current state of virtualization. Respond to the survey and be eligible to win an iPod Touch.
Take the survey now -- ends Aug. 26
Don't Miss Interop New York
See the latest IT solutions at Interop New York. Learn to leverage business technology innovations--including cloud, virtualization, security, mobility, and data center advances--that cut costs, increase productivity, and drive business value. Save 25% on Flex and Conference Passes or get a Free Expo Pass with code CPFHNY25. It happens in New York City, Oct. 3-7, 2011.
This e-mail was sent to %%email%%
Keep This Newsletter Out Of Your SPAM Folder
Don't let future editions of InformationWeek Daily go missing. Take a moment to add the newsletter's address to your anti-spam white list: firstname.lastname@example.org
If you're not sure how to do that, ask your administrator or ISP.
Or check your anti-spam utility's documentation.
We take your privacy very seriously. Please review our Privacy Statement.
We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.